AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34236782 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged mechanical ventilation (PMV) group (group 2 >24 hours)
Number of subjects: 207
Study 34236782 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged mechanical ventilation (PMV)
Number of subjects: 207
Study 34236782 — intervention group
Group type: COMPARATOR
Intervention: Early extubation group (group 1 <24 hours)
Number of subjects: 207
Study 34319926 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction rabbit antithymocyte globulin (rATG) with delayed CNI initiation (day 10)
Number of subjects: 110
Study 34319926 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (upfront CNI commencement)
Number of subjects: 110
Study 34783726 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibiofemoral joint mobilisation in addition to 6 stretching and strengthening exercises of hip and knee muscles with hot pack (Group B)
Number of subjects: 52
Study 34783726 — intervention group
Group type: COMPARATOR
Intervention: 6 stretching and strengthening exercises of hip and knee muscles with hot pack (Group A)
Number of subjects: 52
Study 32270926 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenebrutinib 50 mg once daily
Number of subjects: 578
Study 32270926 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenebrutinib 150 mg once daily
Number of subjects: 578
Study 32270926 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenebrutinib 200 mg twice daily
Number of subjects: 578
Study 32270926 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg every other week
Number of subjects: 578
Study 32270926 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenebrutinib 200 mg twice daily (cohort 2)
Number of subjects: 578
Study 32270926 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 578
Study 34793986 — intervention group
Group type: EXPERIMENTAL
Intervention: Revascularization with stenting
Number of subjects: 879
Study 34793986 — intervention group
Group type: COMPARATOR
Intervention: Optimal medical therapy (OMT)
Number of subjects: 879
Study 34793986 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise therapy (SET) plus OMT
Number of subjects: 879
Study 34793986 — intervention group
Group type: COMPARATOR
Intervention: Real-world cohort (PORTRAIT registry)
Number of subjects: 879
Study 36329596 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolamine (0.1mg/kg intravenous injection 10 min before induction, followed by 2 μg•kg‐1•min‐1 infusion)
Number of subjects: 100
Study 36329596 — intervention group
Group type: COMPARATOR
Intervention: Normal saline infusion (control group)
Number of subjects: 100
Study 32330272 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem
Number of subjects: 0
Study 32330272 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34538227 — intervention group
Group type: EXPERIMENTAL
Intervention: five-flash intense pulsed light therapy (IPL)
Number of subjects: 100
Study 34538227 — intervention group
Group type: COMPARATOR
Intervention: conventional home care alone
Number of subjects: 100
Study 34549388 — intervention group
Group type: EXPERIMENTAL
Intervention: Single intravenous doses of S-oxiracetam (S-ORT) at 2.0 g, 4.0 g, and 8.0 g
Number of subjects: 52
Study 34549388 — intervention group
Group type: EXPERIMENTAL
Intervention: Single intravenous infusion of 3.0 g S-ORT
Number of subjects: 52
Study 34549388 — intervention group
Group type: COMPARATOR
Intervention: Single intravenous infusion of 6.0 g racemic oxiracetam (R-ORT)
Number of subjects: 52
Study 34549388 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily intravenous injection of 4.0 g S-ORT for 7 days
Number of subjects: 52
Study 35331002 — intervention group
Group type: EXPERIMENTAL
Intervention: Steerable ureteroscopic renal evacuation (SURE)
Number of subjects: 17
Study 35331002 — intervention group
Group type: COMPARATOR
Intervention: Basket extraction
Number of subjects: 17
Study 34810345 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic formulation applied for 6 consecutive days
Number of subjects: 10
Study 32143570 — intervention group
Group type: EXPERIMENTAL
Intervention: Paravertebral block combined with general anesthesia (PVB/GA)
Number of subjects: 54
Study 32143570 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia (GA)
Number of subjects: 54
Study 36228640 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily contact testing (DCT) with seven lateral flow device (LFD) tests and two PCR tests, no isolation if negative on LFD.
Number of subjects: 54923
Study 36228640 — intervention group
Group type: COMPARATOR
Intervention: Self-isolation with a single PCR test and 10-day isolation.
Number of subjects: 54923
Study 36228640 — intervention group
Group type: COMPARATOR
Intervention: Comparison of DCT and self-isolation.
Number of subjects: 54923
Study 33826691 — intervention group
Group type: EXPERIMENTAL
Intervention: MED0.5 (0.5 oz lean beef)
Number of subjects: 59
Study 33826691 — intervention group
Group type: EXPERIMENTAL
Intervention: MED2.5 (2.5 oz lean beef)
Number of subjects: 59
Study 33826691 — intervention group
Group type: EXPERIMENTAL
Intervention: MED5.5 (5.5 oz lean beef)
Number of subjects: 59
Study 33826691 — intervention group
Group type: COMPARATOR
Intervention: Average American Diet (AAD)
Number of subjects: 59
Study 35417909 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-weekly somatrogon (0.25, 0.48, and 0.66 mg/kg/week for 12 months)
Number of subjects: 44
Study 35417909 — intervention group
Group type: COMPARATOR
Intervention: Once-daily Genotropin (0.025 mg/kg/day for 12 months)
Number of subjects: 44
Study 35417909 — intervention group
Group type: COMPARATOR
Intervention: Comparison of somatrogon to Genotropin
Number of subjects: 44
Study 33588138 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.4 ml/mg)
Number of subjects: 31
Study 33588138 — intervention group
Group type: COMPARATOR
Intervention: Long-acting betamethasone (0.1 ml/mg)
Number of subjects: 31
Study 36412293 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraosseous anesthesia (IOA)
Number of subjects: 20
Study 36412293 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle-free dental anesthesia (NFA)
Number of subjects: 20
Study 32621599 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine digluconate (CHX) 2% for 30s
Number of subjects: 0
Study 32621599 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium hypochlorite (NaClO) 1% for 30s
Number of subjects: 0
Study 32621599 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium hypochlorite (NaClO) 2.5% for 30s
Number of subjects: 0
Study 32621599 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium hypochlorite (NaClO) 1% for 1min
Number of subjects: 0
Study 32621599 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium hypochlorite (NaClO) 2.5% for 1min
Number of subjects: 0
Study 32621599 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine digluconate (CHX) 2% for 1min
Number of subjects: 0
Study 36330832 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative adapt therapy (IAT)
Number of subjects: 327
Study 36330832 — intervention group
Group type: COMPARATOR
Intervention: Cognitive behavioral therapy (CBT)
Number of subjects: 327
Study 33030089 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 60 mg twice daily
Number of subjects: 143
Study 33030089 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 143
Study 33030089 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 143
Study 32785749 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month follow-up interval
Number of subjects: 20
Study 32785749 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month follow-up interval
Number of subjects: 20
Study 32310040 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-vitamin K antagonist oral anticoagulants
Number of subjects: 12
Study 32310040 — intervention group
Group type: COMPARATOR
Intervention: Dual-drug approach with LMWH-VKA
Number of subjects: 12
Study 33054386 — intervention group
Group type: EXPERIMENTAL
Intervention: FOCAL training program
Number of subjects: 36
Study 33054386 — intervention group
Group type: COMPARATOR
Intervention: Placebo training program
Number of subjects: 36
Study 34858915 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to alpha‐diketones and other VOCs
Number of subjects: 17
Study 34858915 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical evaluations including questionnaire, spirometry, impulse oscillometry, and fractional exhaled nitric oxide
Number of subjects: 17
Study 34858915 — intervention group
Group type: EXPERIMENTAL
Intervention: Engineering controls evaluation
Number of subjects: 17
Study 33141843 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemoadsorption
Number of subjects: 72
Study 33141843 — intervention group
Group type: COMPARATOR
Intervention: Control (no hemoadsorption)
Number of subjects: 72
Study 36286945 — intervention group
Group type: EXPERIMENTAL
Intervention: Aterixen (100 mg tablets)
Number of subjects: 116
Study 36286945 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study 34025069 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic retrograde cholangiopancreatography (ERCP)
Number of subjects: 0
Study 34025069 — intervention group
Group type: COMPARATOR
Intervention: No treatment (wait-and-see approach)
Number of subjects: 0
Study 34351728 — intervention group
Group type: EXPERIMENTAL
Intervention: FAST repetition tempo (1-0-1)
Number of subjects: 13
Study 34351728 — intervention group
Group type: COMPARATOR
Intervention: SLOW repetition tempo (1-0-3)
Number of subjects: 13
Study 33440985 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupressure (AA) applied on four points: shemen, liver, spleen, and finger/toe, thrice daily for 3 weeks
Number of subjects: 120
Study 33440985 — intervention group
Group type: COMPARATOR
Intervention: Sham auricular acupressure applied on four remote points unrelated to neuropathic symptoms, thrice daily for 3 weeks
Number of subjects: 120
Study 35328876 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity home practice and exercise classes
Number of subjects: 589
Study 35328876 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 589
Study 35718794 — intervention group
Group type: EXPERIMENTAL
Intervention: D‐SCAN intervention
Number of subjects: 50
Study 35718794 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 50
Study 34107141 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirulina supplementation (1 g/day, two 500 mg capsules)
Number of subjects: 80
Study 34107141 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 33320461 — intervention group
Group type: EXPERIMENTAL
Intervention: Dried figs
Number of subjects: 99
Study 33320461 — intervention group
Group type: COMPARATOR
Intervention: Cinnamon
Number of subjects: 99
Study 33320461 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 34358773 — intervention group
Group type: EXPERIMENTAL
Intervention: Sound-field amplification (SFA)
Number of subjects: 30
Study 34358773 — intervention group
Group type: COMPARATOR
Intervention: No sound-field amplification (no SFA)
Number of subjects: 30
Study 34972808 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-speculum clinician-taken sampling and self-sampling
Number of subjects: 784
Study 34972808 — intervention group
Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 784
Study 34120329 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest quartile of Dietary Phytochemical Index (DPI)
Number of subjects: 350
Study 34120329 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest quartile of Dietary Phytochemical Index (DPI) after adjustment for potential confounders
Number of subjects: 350
Study 34120329 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest quartile of Dietary Phytochemical Index (DPI) after further adjustment for BMI
Number of subjects: 350
Study 32143961 — intervention group
Group type: EXPERIMENTAL
Intervention: Tearscope Plus (TS)
Number of subjects: 72
Study 32143961 — intervention group
Group type: EXPERIMENTAL
Intervention: Polaris (POL)
Number of subjects: 72
Study 32143961 — intervention group
Group type: EXPERIMENTAL
Intervention: EasyTear Viewplus (ET)
Number of subjects: 72
Study 32143961 — intervention group
Group type: EXPERIMENTAL
Intervention: Keratograph 5 M (KER)
Number of subjects: 72
Study 32143961 — intervention group
Group type: COMPARATOR
Intervention: All instruments (TS, POL, ET, KER)
Number of subjects: 72
Study 36104813 — intervention group
Group type: EXPERIMENTAL
Intervention: HEAT intervention (participatory heat education and supervisor decision-support mobile application)
Number of subjects: 75
Study 36104813 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (alternative-training)
Number of subjects: 75
Study 36104813 — intervention group
Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 75
Study 34688304 — intervention group
Group type: EXPERIMENTAL
Intervention: Public contributor involvement in trial teams
Number of subjects: 21
Study 34688304 — intervention group
Group type: EXPERIMENTAL
Intervention: Public contributor payment
Number of subjects: 21
Study 34688304 — intervention group
Group type: EXPERIMENTAL
Intervention: Training for public contributors
Number of subjects: 21
Study 34688304 — intervention group
Group type: EXPERIMENTAL
Intervention: Tasks undertaken by public contributors
Number of subjects: 21
Study 34688304 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback on public contributor input
Number of subjects: 21
Study 34688304 — intervention group
Group type: EXPERIMENTAL
Intervention: Barriers to successful PPI
Number of subjects: 21
Study 34688304 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful PPI requirements
Number of subjects: 21
Study 34688304 — intervention group
Group type: EXPERIMENTAL
Intervention: CTU's role in PPI
Number of subjects: 21
Study 32579807 — intervention group
Group type: EXPERIMENTAL
Intervention: 320 μg budesonide, 18 μg glycopyrrolate, 9.6 μg formoterol (triple therapy)
Number of subjects: 8509
Study 32579807 — intervention group
Group type: EXPERIMENTAL
Intervention: 160 μg budesonide, 18 μg glycopyrrolate, 9.6 μg formoterol (triple therapy)
Number of subjects: 8509
Study 32579807 — intervention group
Group type: COMPARATOR
Intervention: 18 μg glycopyrrolate, 9.6 μg formoterol (dual therapy)
Number of subjects: 8509
Study 32579807 — intervention group
Group type: COMPARATOR
Intervention: 320 μg budesonide, 9.6 μg formoterol (dual therapy)
Number of subjects: 8509
Study 35210467 — intervention group
Group type: EXPERIMENTAL
Intervention: Active-MTrP-DDN
Number of subjects: 65
Study 35210467 — intervention group
Group type: EXPERIMENTAL
Intervention: Latent-MTrP-DDN
Number of subjects: 65
Study 35210467 — intervention group
Group type: COMPARATOR
Intervention: Non-MTrP-DDN
Number of subjects: 65
Study 32437937 — intervention group
Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) testing
Number of subjects: 773
Study 32437937 — intervention group
Group type: COMPARATOR
Intervention: Antibiotic prescription
Number of subjects: 773
Study 32945066 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-g fecal microbiota transplantation (FMT)
Number of subjects: 142
Study 32945066 — intervention group
Group type: EXPERIMENTAL
Intervention: 60-g fecal microbiota transplantation (FMT)
Number of subjects: 142
Study 32945066 — intervention group
Group type: COMPARATOR
Intervention: Placebo (own feces)
Number of subjects: 142
Study 32203968 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (50,000 IU weekly for 9 weeks)
Number of subjects: 88
Study 32203968 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study 32203968 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation
Number of subjects: 88
Study 35986239 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized treatment strategy based on preoperative risk score
Number of subjects: 119
Study 35986239 — intervention group
Group type: COMPARATOR
Intervention: Control group (no individualized prevention)
Number of subjects: 119
Study 35986239 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized treatment strategy
Number of subjects: 119
Study 35986239 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 119
Study 33484381 — intervention group
Group type: EXPERIMENTAL
Intervention: Stem cell therapy
Number of subjects: 3142
Study 33484381 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 3142
Study 32245060 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention including professional skills training sessions and team communication.
Number of subjects: 241
Study 32245060 — intervention group
Group type: COMPARATOR
Intervention: Control group following the routine work plan.
Number of subjects: 241
Study 32245060 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention.
Number of subjects: 241
Study 35333352 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive breast milk nutritional support program (IBNSP) with breastfeeding, administered for the first 48 hours after birth, including face-to-face training and practical support.
Number of subjects: 68
Study 35333352 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive breast milk nutritional support program (IBNSP) with breastfeeding.
Number of subjects: 68
Study 35333352 — intervention group
Group type: COMPARATOR
Intervention: Standard care recommended by the World Health Organization (Control group).
Number of subjects: 68
Study 34213672 — intervention group
Group type: EXPERIMENTAL
Intervention: Genicular nerve block (GNB)
Number of subjects: 64
Study 34213672 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular triamcinolone
Number of subjects: 64
Study 33370134 — intervention group
Group type: EXPERIMENTAL
Intervention: Body Project intervention (peer-delivered)
Number of subjects: 112
Study 33370134 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only control
Number of subjects: 112
Study 34802302 — intervention group
Group type: EXPERIMENTAL
Intervention: Play Nicely online program (n = 21)
Number of subjects: 52
Study 34802302 — intervention group
Group type: COMPARATOR
Intervention: Control condition website (n = 31)
Number of subjects: 52
Study 32149773 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone via intravenous injection at a dose of 1-2 mg/kg/day for 3 days
Number of subjects: 48
Study 32149773 — intervention group
Group type: COMPARATOR
Intervention: No glucocorticoid use (Control)
Number of subjects: 48
Study 32149773 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 48
Study 36003030 — intervention group
Group type: EXPERIMENTAL
Intervention: Instrumental reminiscence therapy based on Roy's adaptation model
Number of subjects: 34
Study 36003030 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 34
Study 34146513 — intervention group
Group type: EXPERIMENTAL
Intervention: ICP monitoring
Number of subjects: 2395
Study 33092707 — intervention group
Group type: EXPERIMENTAL
Intervention: TMVr with the MitraClip plus guideline-directed medical therapy (GDMT)
Number of subjects: 0
Study 33092707 — intervention group
Group type: COMPARATOR
Intervention: GDMT alone
Number of subjects: 0
Study 34481803 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedosiran (1.5, 3.0, or 6.0 mg/kg)
Number of subjects: 18
Study 34481803 — intervention group
Group type: COMPARATOR
Intervention: Nedosiran (0.3, 1.5, 3.0, 6.0, then 12.0 mg/kg)
Number of subjects: 18
Study 34481803 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 34688281 — intervention group
Group type: EXPERIMENTAL
Intervention: Program intervention (PA4E1)
Number of subjects: 49
Study 34688281 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 49
Study 33191341 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowest DKK3 tertile
Number of subjects: 550
Study 33191341 — intervention group
Group type: COMPARATOR
Intervention: DKK3 tertiles 1-3
Number of subjects: 550
Study 33191341 — intervention group
Group type: COMPARATOR
Intervention: DKK3 levels
Number of subjects: 550
Study 34362453 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal injection of umbilical cord tissue mesenchymal stem cells (UCT‐MSC), single-dose (2 × 10^7) cells.
Number of subjects: 72
Study 33000588 — intervention group
Group type: EXPERIMENTAL
Intervention: Xiaoyin Jiedu (XYJD) granules
Number of subjects: 25
Study 33000588 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 32063367 — intervention group
Group type: EXPERIMENTAL
Intervention: Abbreviated perioperative care bundle (APCB)
Number of subjects: 74
Study 32063367 — intervention group
Group type: COMPARATOR
Intervention: Standard perioperative care
Number of subjects: 74
Study 36402988 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD clinical decision support (CDS) system
Number of subjects: 314
Study 36402988 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 314
Study 34768600 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.8 mg) and Bupivacaine (5%) with articaine–epinephrine (40/0.005 mg/mL)
Number of subjects: 184
Study 34768600 — intervention group
Group type: COMPARATOR
Intervention: Articaine–epinephrine (40/0.005 mg/mL)
Number of subjects: 184
Study 35288059 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion-focused behavioral intervention
Number of subjects: 216
Study 35288059 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 216
Study 34481524 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g tranexamic acid (TXA) administered immediately after induction of general anesthesia
Number of subjects: 40
Study 34481524 — intervention group
Group type: COMPARATOR
Intervention: No TXA (control group)
Number of subjects: 40
Study 34332050 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramedullary unicortical button
Number of subjects: 20
Study 34332050 — intervention group
Group type: COMPARATOR
Intervention: All-suture anchors
Number of subjects: 20
Study 32305787 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia alone (control group)
Number of subjects: 99
Study 32305787 — intervention group
Group type: EXPERIMENTAL
Intervention: Very-low-dose spinal analgesia (levobupivacaine 3.75 mg; sufentanil 2.5 μg)
Number of subjects: 99
Study 32305787 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose spinal analgesia (levobupivacaine 7.5 mg; sufentanil 2.5 μg)
Number of subjects: 99
Study 32305787 — intervention group
Group type: EXPERIMENTAL
Intervention: Very-low-dose spinal analgesia
Number of subjects: 99